Lauren Tengler | executive |
Michael Mahoney | executive |
Daniel Brennan | executive |
Robert Marcus | analyst |
Joanne Wuensch | analyst |
Ken Stein | executive |
Frederick Wise | analyst |
Larry Biegelsen | analyst |
Travis Steed | analyst |
Vijay Kumar | analyst |
Danielle Antalffy | analyst |
Cecilia Furlong | analyst |
Matthew Taylor | analyst |
Matthew Miksic | analyst |
Christopher Pasquale | analyst |
Good morning, everyone, and welcome to the Boston Scientific First Quarter 2023 Earnings Call. [Operator Instructions] Please also note today's event is being recorded. At this time, I'd like to turn the floor over to Lauren Tengler, Vice President, Investor Relations. Please go ahead.
Thank you, Jamie.